877041-47-9 Usage
General Description
6-(tert-butyl) 3-methyl 2-amino-4,7-dihydrothieno[2,3-c]pyridine-3,6(5H)-dicarboxylate is a chemical compound with a complex molecular structure that includes a thieno ring, a pyridine ring, and two carboxylate groups. It is a dicarboxylate ester derivative, meaning it contains two ester groups. The compound also includes a tert-butyl group and a methyl group, making it a highly substituted molecule. The presence of an amino group indicates that it is a basic compound. Overall, this compound is a highly specialized and potentially unique molecule with potential applications in various fields of organic chemistry and pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 877041-47-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,7,0,4 and 1 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 877041-47:
(8*8)+(7*7)+(6*7)+(5*0)+(4*4)+(3*1)+(2*4)+(1*7)=189
189 % 10 = 9
So 877041-47-9 is a valid CAS Registry Number.
InChI:InChI=1/C14H20N2O4S/c1-14(2,3)20-13(18)16-6-5-8-9(7-16)21-11(15)10(8)12(17)19-4/h5-7,15H2,1-4H3
877041-47-9Relevant articles and documents
Preparation method and application of selective butyryl cholinesterase inhibitor. (by machine translation)
-
Paragraph 0048-0050, (2020/03/12)
The invention discloses a preparation method and application (I) of the selective butyryl cholinesterase inhibitor, with the general formula. to evaluate the selectivity of cholinesterase inhibition activity, to find that it has good in-vitro activity and
NOVEL COMPOUND HAVING ANGIOGENESIS INHIBITORY ACTIVITY, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
-
Paragraph 0047; 0048; 00453; 00454, (2014/07/23)
Disclosed are an anti-angiogenic compound, represented by Chemical Formula I, or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a pharmaceutically acceptable composition including the same. Because the compound of Chemical Formular I potently suppresses the angiogenesis, the compound of Chemical Formula I is applicable to the prevention and treatment of diseases caused by aberrant activity of vascular endothelial growth factor, and available as an anti-angiogenic agent.